top of page
COVID-19 Information Center
COVID-19 Information Center
COVID-19 Information Center
Innovation Program
Innovation Program
Innovation Program
Insights
Topic 1: Translational Medicine
Moderators
DENG Shaoping, President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
SHI Yuankai, Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials
ZHANG Xiangcheng
Industry Fellow, Royal Society, United Kingdom
Topic: Innovation in Science and Collaboration: the Past, Present, and Future
YANG Zhenglin
Vice President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
Topic: Research and Application of Age-related Macular Degeneration in China
YANG Shengyong
Professor, Sichuan University
Topic: Artificial Intelligence and Innovative Medicine Development
Lilach O. Lerman
Professor of Medicine and Physiology in the Mayo Medical School; Director of the Renovascular Research Laboratory, and Head of the Nephrology Research Unit at the Division of Nephrology & Hypertension at Mayo Clinic
Topic: The Obesity Epidemic: Weight and Beyond
Topic 2: Precision Medicine
Moderators
RAO Keqin, Vice President and Chairman, Chinese Medical Association; President, Chinese Health Economics Association
WU Qi, Human Resources and Social Security Department of Sichuan
WEI Yuquan
Director of State Key Laboratory of Biotherapy and Cancer
Center, West China Hospital, Sichuan University; Academician, Chinese Academy of Sciences
Topic: Tumor Micro-environment and Development of Biology Medicine
XU Mei
President, International Richland Hospital, Kunming, Yunnan
Topic: Searching for Cause for Diseases
SHI Yuankai
Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials
Topic: Current Status and Prospects of Clinical Research on New Cancer Drugs in China
James Meng
President, Mevion Medical Systems, Boston, U.S.
Topic: Precision Cancer Treatment with Miniaturized Proton
Anita Katharina Wagner
Clinical Pharmacist, Pharmacoepidemiologist, and
Health Policy Researcher, Department of Population Medicine of Harvard Medical School & Harvard Pilgrim Health Care Institute
Topic: New Cancer Therapeutics in Health Systems – Opportunities and Challenges
Panel Discussion
Moderator:
MA Jing, Director, China Center, Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care InstituteHE Xin, Managing Partner, Hyfinity Investments
Above Speakers
SHI Anli, President, Cancer Rehabilitation Society of China Anti-Cancer Association
bottom of page